OmniAb, Inc. (OABI)
2.11
-0.18
(-7.86%)
USD |
NASDAQ |
Jul 13, 16:00
2.11
0.00 (0.00%)
After-Hours: 20:00
OmniAb Gross Profit Margin (Quarterly) : 49.89% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 49.89% |
| December 31, 2025 | 7.88% |
| September 30, 2025 | -109.2% |
| June 30, 2025 | -26.02% |
| March 31, 2025 | -14.18% |
| December 31, 2024 | 54.59% |
| September 30, 2024 | -18.10% |
| June 30, 2024 | 19.87% |
| March 31, 2024 | -30.20% |
| Date | Value |
|---|---|
| December 31, 2023 | -2.32% |
| September 30, 2023 | 11.56% |
| June 30, 2023 | 30.03% |
| March 31, 2023 | 74.18% |
| December 31, 2022 | 90.73% |
| September 30, 2022 | 34.85% |
| June 30, 2022 | 37.64% |
| March 31, 2022 | 58.38% |
| December 31, 2021 | 78.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 25.85% |
| Inotiv, Inc. | 8.98% |
| Champions Oncology, Inc. | 44.59% |
| Medpace Holdings, Inc. | 26.81% |
| Charles River Laboratories International, Inc. | 30.90% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.22% |
| Return on Assets | -17.65% |
| Return on Invested Capital | -18.74% |
| Profit Margin (Quarterly) | -53.42% |
| Operating Margin (Quarterly) | -56.48% |
| Return on Net Operating Assets | -21.85% |